{"title":"缺血心脏心肌能量代谢的扰动","authors":"","doi":"10.31887/hm.2020.81/jussher","DOIUrl":null,"url":null,"abstract":"As an organ that must continuously pump oxygenated blood throughout the body, the heart has an\nenormous metabolic demand, which is primarily met via oxidative metabolism of fatty acids and carbohydrates.\nBecause of its high metabolic demand, during times of reduced oxygen supply such as ischemia, the heart\nbecomes highly susceptible to injury, and if flow is not re-established, myocardial tissue is lost and can result\nin death (myocardial infarction). Of interest, both myocardial ischemia and reperfusion are associated with a\nnumber of perturbations in energy metabolism that contribute to the pathology of ischemic heart disease. This\nincludes marked elevations in glycolysis to counteract the reduction in oxidative metabolism, whereas fatty acids\npredominate as the primary fuel source for residual oxidative metabolism. During the early stages of cardiac\nrecovery after successful reperfusion of the ischemic heart, fatty acid oxidation rates also rapidly recover at\nthe expense of low glucose oxidation rates. These metabolic perturbations increase myocardial acidosis due\nto glycolysis being uncoupled from glucose oxidation, which impairs cardiac efficiency. As such, therapeutic\napproaches to stimulate glucose oxidation or inhibit fatty acid oxidation have the potential to correct dysregulated myocardial energy metabolism during ischemia and reperfusion, which improves cardiac efficiency and\nmay lead to improved clinical outcomes in people with ischemic heart disease. L","PeriodicalId":35477,"journal":{"name":"Heart and Metabolism","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Perturbations in myocardial energy metabolism in the ischemic heart\",\"authors\":\"\",\"doi\":\"10.31887/hm.2020.81/jussher\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"As an organ that must continuously pump oxygenated blood throughout the body, the heart has an\\nenormous metabolic demand, which is primarily met via oxidative metabolism of fatty acids and carbohydrates.\\nBecause of its high metabolic demand, during times of reduced oxygen supply such as ischemia, the heart\\nbecomes highly susceptible to injury, and if flow is not re-established, myocardial tissue is lost and can result\\nin death (myocardial infarction). Of interest, both myocardial ischemia and reperfusion are associated with a\\nnumber of perturbations in energy metabolism that contribute to the pathology of ischemic heart disease. This\\nincludes marked elevations in glycolysis to counteract the reduction in oxidative metabolism, whereas fatty acids\\npredominate as the primary fuel source for residual oxidative metabolism. During the early stages of cardiac\\nrecovery after successful reperfusion of the ischemic heart, fatty acid oxidation rates also rapidly recover at\\nthe expense of low glucose oxidation rates. These metabolic perturbations increase myocardial acidosis due\\nto glycolysis being uncoupled from glucose oxidation, which impairs cardiac efficiency. As such, therapeutic\\napproaches to stimulate glucose oxidation or inhibit fatty acid oxidation have the potential to correct dysregulated myocardial energy metabolism during ischemia and reperfusion, which improves cardiac efficiency and\\nmay lead to improved clinical outcomes in people with ischemic heart disease. L\",\"PeriodicalId\":35477,\"journal\":{\"name\":\"Heart and Metabolism\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Heart and Metabolism\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31887/hm.2020.81/jussher\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31887/hm.2020.81/jussher","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Perturbations in myocardial energy metabolism in the ischemic heart
As an organ that must continuously pump oxygenated blood throughout the body, the heart has an
enormous metabolic demand, which is primarily met via oxidative metabolism of fatty acids and carbohydrates.
Because of its high metabolic demand, during times of reduced oxygen supply such as ischemia, the heart
becomes highly susceptible to injury, and if flow is not re-established, myocardial tissue is lost and can result
in death (myocardial infarction). Of interest, both myocardial ischemia and reperfusion are associated with a
number of perturbations in energy metabolism that contribute to the pathology of ischemic heart disease. This
includes marked elevations in glycolysis to counteract the reduction in oxidative metabolism, whereas fatty acids
predominate as the primary fuel source for residual oxidative metabolism. During the early stages of cardiac
recovery after successful reperfusion of the ischemic heart, fatty acid oxidation rates also rapidly recover at
the expense of low glucose oxidation rates. These metabolic perturbations increase myocardial acidosis due
to glycolysis being uncoupled from glucose oxidation, which impairs cardiac efficiency. As such, therapeutic
approaches to stimulate glucose oxidation or inhibit fatty acid oxidation have the potential to correct dysregulated myocardial energy metabolism during ischemia and reperfusion, which improves cardiac efficiency and
may lead to improved clinical outcomes in people with ischemic heart disease. L